IOH-005

N/A

Report date: 2025/09/29 14:28:14

Base Information

Drug NameIOH-005
Drug Alias NameIOH-005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Lymphocyte activation gene 3 proteinCytokines modulators
TargetsLymphocyte activation gene 3 proteinCytokines
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmuneoncia Therapeutics IncProGen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProGen Co LtdImmuneoncia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A